VaramirStart free · no cardSign in
URGN as of Nov 1 · 08:20 ET
URGNNasdaqPharmaceutical Preparations

UroGen Pharma Ltd. · Brief

Next report

4 days

Nov 5 · before openest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
1 of 8≥ implied
avg implied
±15.2%
avg realized
±9.6%
Nov 6 '24±7.2%▲+0.25%×0.03
Mar 10 '25±15.1%▲+1.02%×0.07
May 12 '25±13.9%▲+7.32%×0.53
Aug 7 '25±10.6%▼−7.10%×0.67
Nov 6 '25±22.6%▲+21.91%×0.97
Q1 FY26±20.4%▼−12.35%×0.61
May 6 '26±16.0%▲+10.16%×0.64
Q2 FY26±16.0%▲+16.31%×1.02
quarterimplied−25%0+25%realized×
Q2 FY26±16.0%▲+16.31%×1.02
May '26±16.0%▲+10.16%×0.64
Q1 FY26±20.4%▼−12.35%×0.61
Nov '25±22.6%▲+21.91%×0.97
Aug '25±10.6%▼−7.10%×0.67
May '25±13.9%▲+7.32%×0.53
2 older reports
Mar '25±15.1%▲+1.02%×0.07
Nov '24±7.2%▲+0.25%×0.03
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 5 report · est.

Bull2 of 3

6disclosed supplier and customer ties in SEC filingsSEC filings
190managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 3

7 of 8recent reports where the move came in under the options implied rangeEarnings history
3 of 24largest reporting managers who cut their stake in the latest quarter13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

URGN report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 22impliedImplied move: ±14.2% into Nov 5 earnings (Oct 22 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.